Optimizing Prosthetic Prescription to Mitigate the Effects of Perspiration

NCT ID: NCT07024342

Last Updated: 2026-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

180 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-04

Study Completion Date

2026-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The specific aim of this research is to compare three clinically available liners, each intended to address problems of residual limb perspiration, with the as-prescribed liner of lower limb prosthesis user and determine their effect on stability, suspension, and comfort.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objective of the proposed research is to provide the individual with a below-knee amputation a prosthesis that best addresses problems of perspiration and its accumulation inside the prosthesis. A concern of every individual with a lower limb prosthesis is keeping their residual limb healthy and injury free. Naturally occurring perspiration, induced by moderate to vigorous activity or hot and humid environments, leads to perspiration. While the modern prosthetic liner can be stable, secure, and comfortable when dry, the materials from which they are made trap heat and are impermeable to moisture. When perspiration accumulation is a frequent occurrence, a host of biomechanical and skin problems can arise. Clinicians have few available options to prevent perspiration accumulation inside the prosthesis.

For individuals who do have problems with residual limb perspiration, some may be able to stop their activity when it accumulates, remove their prosthesis, dry it and their residual limb, then don it again and carry on. Others, like the military service personnel, may not have such an opportunity. These individuals can be prescribed a perforated liner through which perspiration can drain, or a thin, special purpose half-ply sock worn between the skin and liner, which can reduce the lubricating effects of perspiration. Current commercially-available perforated liners come with two different sized holes: one with small holes the size of a pinprick, and one with somewhat larger holes the size of a pinhead. There is little evidence available to suggest which of the three approaches is best.

The aim of the proposed research is to compare these three clinically-available options and determine which is best at addressing the problem of perspiration accumulation inside the prosthesis. To achieve this aim, we propose to recruit 180 individuals with below-knee amputations to participate in a human subject experiment. Upon enrollment, we will administer a survey to measure the stability, suspension, and comfort of their socket. Subjects will then receive one of three study-provided liners: (1) a liner-liner, (2) a liner perforated with very small diameter holes, or (3) a liner perforated with somewhat larger diameter holes. After subjects have worn the study-provided liner for two weeks, we will administer the survey again. The results of this research will identify which of the three clinically-available options is best at addressing the problem of perspiration accumulation inside the prosthesis.

More than half a million Americans live with a lower limb amputation, and a few thousand of these were on active duty when it happened. For the many individuals with a lower limb amputation who have problems with perspiration, the results of this two-year study will be of value as it will help them, and their clinicians, choose the best commercially-available solution.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Amputation Prosthesis User

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A between-subjects, repeated measures experiment will be conducted with individuals with unilateral transtibial limb loss (n=180) who are successful ambulators and have issues with perspiration by self-report. Baseline measurements will be obtained at the time of enrollment while participants are wearing their as-prescribed liner. After wearing the randomly assigned study intervention for two weeks, measurements will be repeated.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Liner perforated with very small diameter holes

Subjects will wear their prosthesis in their home, work, and community environments while they will participate in their usual activities for two weeks.

Group Type EXPERIMENTAL

Liner perforated with very small diameter holes

Intervention Type DEVICE

A commercially available, elastomeric liner perforated with very small holes (approximately 0.3 mm diameter) to allow perspiration to drain. This liner is worn between the skin and the participant's prosthetic socket.

As-prescribed liner

Intervention Type DEVICE

A commercially available, elastomeric liner with no perforations. This liner is worn between the skin and the participant's prosthetic socket.

Liner perforated with somewhat larger diameter holes

Subjects will wear their prosthesis in their home, work, and community environments while they will participate in their usual activities for two weeks.

Group Type EXPERIMENTAL

Liner perforated with somewhat larger diameter holes

Intervention Type DEVICE

A commercially available, elastomeric liner perforated with somewhat larger holes (approximately 1.5 mm diameter) to allow perspiration to drain. This liner is worn between the skin and the participant's prosthetic socket.

As-prescribed liner

Intervention Type DEVICE

A commercially available, elastomeric liner with no perforations. This liner is worn between the skin and the participant's prosthetic socket.

Liner-liner

Subjects will wear their prosthesis in their home, work, and community environments while they will participate in their usual activities for two weeks.

Group Type EXPERIMENTAL

Liner-liner

Intervention Type DEVICE

A thin, special purpose half-ply sock which may reduce the effects of perspiration. The liner-liner is worn between the skin and the participant's as-prescribed liner.

As-prescribed liner

Intervention Type DEVICE

A commercially available, elastomeric liner with no perforations. This liner is worn between the skin and the participant's prosthetic socket.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Liner perforated with very small diameter holes

A commercially available, elastomeric liner perforated with very small holes (approximately 0.3 mm diameter) to allow perspiration to drain. This liner is worn between the skin and the participant's prosthetic socket.

Intervention Type DEVICE

Liner perforated with somewhat larger diameter holes

A commercially available, elastomeric liner perforated with somewhat larger holes (approximately 1.5 mm diameter) to allow perspiration to drain. This liner is worn between the skin and the participant's prosthetic socket.

Intervention Type DEVICE

Liner-liner

A thin, special purpose half-ply sock which may reduce the effects of perspiration. The liner-liner is worn between the skin and the participant's as-prescribed liner.

Intervention Type DEVICE

As-prescribed liner

A commercially available, elastomeric liner with no perforations. This liner is worn between the skin and the participant's prosthetic socket.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SoftSkin Air S30; Uniprox, Zeulenroda-Triebes, GER Silcare Breathe Cushion Liner; Endolite, Miamisburg, OH, USA Liner-liner; Knit-Rite, Kansas City, KS, USA Alpha Classic or Alpha Hybrid; WillowWood; Mt. Sterling, OH, USA

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Unilateral transtibial amputation
* Been fit with a prosthesis and used it for at least six months
* Wear the prosthesis for four or more hours on average per day
* Have, or will have access to a computer, tablet, or smartphone with video conferencing ability
* Currently have problems with residual limb perspiration
* Currently wear a WillowWood Alpha Classic or Alpha Hybrid liner

Exclusion Criteria

* Improper fit and suspension with current prosthesis and one cannot be achieved with clinical resources
* Residual limb is ulcerated
* Current skin irritation or injury on residual limb
* Osteoarthritis, injury, or pain that interferes with walking ability
* Currently incarcerated
* Pregnant
* Inadequate cognitive function or language proficiency to consent to participate
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VA Puget Sound Health Care System

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Glenn K. Klute, PhD

Research Career Scientist / Affiliate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Glenn K Klute, PhD

Role: PRINCIPAL_INVESTIGATOR

US Department of Veterans Affairs

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

VA Puget Sound Health Care System Seattle Division

Seattle, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1588234

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.